返回 Agenda
Challenges in Advanced Therapy Development: A New Community
Session Chair(s)
Kirsten Messmer, PHD, RAC
Owner
KM Intel LLC, United States
Advanced therapies face very unique challenges at every stage of development and beyond marketing. DIA is launching a new Advanced Therapy Community to facilitate cross-functional discussion of every aspect of advanced therapy development.
Learning Objective : Identify the complexity and challenges of advanced therapy development from the preclinical conception throughout clinical development through development and post-approval cost and monitoring implications; Discuss the benefit of joining the new Advanced Therapy Community and attending the monthly online meetings.
Speaker(s)
Facilitator
Richard Dennett, DRSC
PPD, France
Senior Director Regulatory Affairs CMC